Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px
Document › Details

Bavarian Nordic A/S. (8/25/17). "Press Release: Bavarian Nordic Announces First Half 2017 Results". Copenhagen.

Organisation Organisation Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY)
  Group Bavarian Nordic (Group)
Products Product MVA-BN® technology (Modified Vaccinia Ankara)
  Product 2 AdVac® technology
Index term Index term JnJ–Bavarian Nordic: vaccine technology
Persons Person Kainu, Tommi (Bavarian Nordic 201707– CBO before Boston Consulting + NIH)
  Person 2 Chaplin, Paul (Bavarian Nordic 201410 CEO)
     


   
Record changed: 2017-08-30

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

More documents for Bavarian Nordic (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnering Open 600x60px




» top